Register | Login

Trial that compared initial treatment together with the combination of leucovorin, 5-FU, and irinotecan (FOLFIRI) for the exact same therapy with cetuximab, there was a significant interaction among KRAS mutation status and survival outcome (9). Quite a few other equivalent studies and also a meta-analysis came to similar conclusions (12,39-41). Thus, KRAS mutation testing has been integrated into

Who Voted for this Story


Comments



Instant Approval Social Bookmarking Websites

http://www.247prever.com/

http://ib2biz.com/

http://247ebook.co.uk/

http://savelivelife.com/

http://hollywoodbollywood.me/

http://congressdigital.com/

http://marketing.ib2biz.com/



Pligg is an open source content management system that lets you easily create your own social network.

Username:

Password:

Remember: